Atlas Trials

Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma

Clinical trial NCT00961844 · TERMINATED

Trial details

NCT number
NCT00961844
Sponsor
Steinar Aamdal
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Malignant Melanoma
Start date
2009-08-01
Primary completion
2012-06-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.